ATE440107T1 - Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffe - Google Patents
Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffeInfo
- Publication number
- ATE440107T1 ATE440107T1 AT05019255T AT05019255T ATE440107T1 AT E440107 T1 ATE440107 T1 AT E440107T1 AT 05019255 T AT05019255 T AT 05019255T AT 05019255 T AT05019255 T AT 05019255T AT E440107 T1 ATE440107 T1 AT E440107T1
- Authority
- AT
- Austria
- Prior art keywords
- tumor
- molecules
- tumour
- present
- relates
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000000259 anti-tumor effect Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05019255A EP1760089B1 (en) | 2005-09-05 | 2005-09-05 | Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE440107T1 true ATE440107T1 (de) | 2009-09-15 |
Family
ID=35149455
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05019255T ATE440107T1 (de) | 2005-09-05 | 2005-09-05 | Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffe |
| AT06777167T ATE494303T1 (de) | 2005-09-05 | 2006-09-05 | An humane leukozytenantigen-(hla-)klasse-i- oder ii-moleküle bindende tumorassoziierte peptide und damit im zusammenhang stehender impfstoff gegen krebs |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06777167T ATE494303T1 (de) | 2005-09-05 | 2006-09-05 | An humane leukozytenantigen-(hla-)klasse-i- oder ii-moleküle bindende tumorassoziierte peptide und damit im zusammenhang stehender impfstoff gegen krebs |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20090274714A1 (enExample) |
| EP (2) | EP1760089B1 (enExample) |
| JP (1) | JP5132561B2 (enExample) |
| KR (1) | KR101150663B1 (enExample) |
| CN (1) | CN101287755B (enExample) |
| AT (2) | ATE440107T1 (enExample) |
| AU (1) | AU2006289289B2 (enExample) |
| BR (1) | BRPI0615466A2 (enExample) |
| CA (1) | CA2621414C (enExample) |
| CY (2) | CY1110536T1 (enExample) |
| DE (2) | DE602005016112D1 (enExample) |
| DK (2) | DK1760089T3 (enExample) |
| EA (1) | EA013466B1 (enExample) |
| ES (2) | ES2330013T3 (enExample) |
| HR (1) | HRP20110240T1 (enExample) |
| NO (1) | NO20081690L (enExample) |
| NZ (1) | NZ565956A (enExample) |
| PL (2) | PL1760089T3 (enExample) |
| PT (2) | PT1760089E (enExample) |
| RS (1) | RS51893B (enExample) |
| SI (2) | SI1760089T1 (enExample) |
| UA (2) | UA97095C2 (enExample) |
| WO (1) | WO2007028573A1 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005020046D1 (de) * | 2005-09-05 | 2010-04-29 | Immatics Biotechnologies Gmbh | Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| ES2321680B1 (es) * | 2007-04-26 | 2010-03-05 | Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental - Alejandro Otero (Fibao) | Restauracion de las moleculas hla de clase i mediante terapia genica empleando vectores adenovirales portando el gen de la beta 2-microglobulina. |
| PL2183361T3 (pl) | 2007-07-27 | 2015-10-30 | Immatics Biotechnologies Gmbh | Innowacyjna immunoterapia przeciwko nowotworom mózgu |
| PL2562182T3 (pl) * | 2007-07-27 | 2016-03-31 | Immatics Biotechnologies Gmbh | Nowe immunogenne epitopy do immunoterapii |
| JP5352586B2 (ja) * | 2007-07-27 | 2013-11-27 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 腫瘍関連ペプチドおよび関連抗癌ワクチンの組成物 |
| CY1112212T1 (el) * | 2008-04-24 | 2015-12-09 | Immatics Biotechnologies Gmbh | Νεα σκευασματα πεπτιδιων που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης i ή ii για εμβολια |
| ES2342506T3 (es) * | 2008-04-30 | 2010-07-07 | Immatics Biotechnologies Gmbh | Novedosas formulaciones para vacunas de peptidos asociados a tumores, unidos a moleculas del antigeno de leucocito humano (hla) de clase i o ii. |
| DK2119726T5 (en) * | 2008-05-14 | 2018-03-26 | Immatics Biotechnologies Gmbh | Novel and powerful MHC class II peptides derived from survivin and neurocan |
| RS53782B1 (sr) | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera |
| AU2016204708B2 (en) * | 2008-10-01 | 2018-02-22 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201009222D0 (en) | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| TWI618541B (zh) * | 2010-12-02 | 2018-03-21 | 腫瘤療法 科學股份有限公司 | Ｔｏｍｍ３４胜肽與含此胜肽之疫苗 |
| ES2647768T3 (es) * | 2011-07-05 | 2017-12-26 | Cadila Pharmaceuticals Limited | Antígeno de cáncer |
| MY170949A (en) * | 2011-07-11 | 2019-09-20 | Cancer Res Initiatives Foundation | A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
| RU2671707C2 (ru) | 2012-06-27 | 2018-11-06 | Рутгерс, Дзе Стейт Юниверсити Оф Нью-Джерси | Экспресс-анализы активации т-клеток, основанные на измерении рнк с использованием проточной цитометрии |
| US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
| TWI819228B (zh) * | 2013-08-05 | 2023-10-21 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（八） |
| KR20160097290A (ko) | 2013-12-09 | 2016-08-17 | 타르고바스 에이에스에이 | 펩타이드 혼합물 |
| HRP20192212T4 (hr) | 2014-12-23 | 2022-11-25 | Immatics Biotechnologies Gmbh | Novi peptidi i kombinacije peptida za upotrebu u imunoterapiji protiv hepatocelularnog karcinoma (hcc) i drugih rakova |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| ES2790725T3 (es) * | 2015-03-16 | 2020-10-29 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Procedimiento de detección de nuevos epítopos de células T inmunogénicas y aislamiento de nuevos receptores de células T específicas de antígeno mediante una biblioteca de células de MHC |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| MY190083A (en) | 2015-03-17 | 2022-03-25 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| PH12021550850A1 (en) | 2015-03-27 | 2022-10-03 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various tumors |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| GB201505585D0 (en) | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| GB201510771D0 (en) | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
| IL292697A (en) | 2015-06-19 | 2022-07-01 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers |
| HK1254866A1 (zh) | 2015-06-25 | 2019-07-26 | Immatics Biotechnologies Gmbh | 用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物 |
| GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| MA42294B1 (fr) | 2015-07-01 | 2020-11-30 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| CA3221001A1 (en) | 2015-07-06 | 2017-01-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers |
| GB201511792D0 (en) | 2015-07-06 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers |
| MY189596A (en) | 2015-07-15 | 2022-02-18 | Immatics Biotechnologies Gmbh | A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| GB201517538D0 (en) | 2015-10-05 | 2015-11-18 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| MY198087A (en) | 2015-10-05 | 2023-07-31 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| EP3167898A1 (en) | 2015-11-11 | 2017-05-17 | IEO - Istituto Europeo di Oncologia Srl | Method for obtaining tumor peptides and uses thereof |
| WO2017096247A1 (en) * | 2015-12-04 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Methods and vaccines for inducing immune responses to multiple different mhc molecules |
| GB201521894D0 (en) * | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| IL298653A (en) | 2015-12-11 | 2023-01-01 | Immatics Biotechnologies Gmbh | New peptides and a combination of peptides for use in immunotherapy against several types of cancer |
| JP2019512263A (ja) * | 2016-02-22 | 2019-05-16 | オーシャンサイド バイオテクノロジー | 免疫療法におけるネオ抗原組成物及び同組成物を使用する方法 |
| AU2017240745B2 (en) * | 2016-03-31 | 2021-08-19 | Biontech Us Inc. | Neoantigens and methods of their use |
| TWI796299B (zh) * | 2016-08-26 | 2023-03-21 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| KR102639592B1 (ko) | 2016-12-08 | 2024-02-21 | 이매틱스 바이오테크놀로지스 게엠베하 | 짝짓기가 향상된 t 세포 수용체 |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| CN106986932A (zh) * | 2017-04-06 | 2017-07-28 | 海口市人民医院 | 一种c‑Met表位肽及其应用 |
| KR102267463B1 (ko) * | 2018-02-15 | 2021-06-21 | 코쿠리츠다이가쿠호진 아사히카와 이카다이가쿠 | 암 항원 펩티드 |
| CN110804642B (zh) * | 2019-09-10 | 2022-06-21 | 清华大学 | Gpr174免疫学功能及其用途 |
| WO2021096446A1 (en) * | 2019-11-14 | 2021-05-20 | Bogazici Universitesi | Asc specks in cancer immunotherapy |
| CN114524870A (zh) * | 2020-11-23 | 2022-05-24 | 香雪生命科学技术（广东）有限公司 | 源自于ssx2抗原的短肽 |
| CA3216268A1 (en) * | 2021-04-23 | 2022-10-27 | Scott Burkholz | Vaccine for sars-cov-2 |
| CN118620040A (zh) * | 2022-01-05 | 2024-09-10 | 成都朗谷生物科技股份有限公司 | 一种针对乙型肝炎病毒的抗原肽 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| IE53176B1 (en) | 1978-12-22 | 1988-08-17 | Biogen Nv | Recombinant dna molecules and their method of production |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| DE69332485T2 (de) * | 1992-08-11 | 2003-11-13 | The President And Fellows Of Harvard College, Cambridge | Immunmodulierende peptide |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| NZ290089A (en) | 1994-07-27 | 1999-05-28 | Queensland Inst Med Res | Recombinant polyepitope cytotoxic t lymphocyte (ctl) vaccines |
| DE69723230T2 (de) | 1996-01-17 | 2004-05-27 | Imperial College Innovations Ltd. | Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl) |
| US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
| KR100358068B1 (ko) * | 1999-12-28 | 2002-10-25 | 주식회사 하이닉스반도체 | 플래쉬 메모리 소자의 제조방법 |
| WO2004014867A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| US20060045881A1 (en) * | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
-
2005
- 2005-09-05 SI SI200530796T patent/SI1760089T1/sl unknown
- 2005-09-05 AT AT05019255T patent/ATE440107T1/de active
- 2005-09-05 DK DK05019255T patent/DK1760089T3/da active
- 2005-09-05 PL PL05019255T patent/PL1760089T3/pl unknown
- 2005-09-05 ES ES05019255T patent/ES2330013T3/es not_active Expired - Lifetime
- 2005-09-05 DE DE602005016112T patent/DE602005016112D1/de not_active Expired - Lifetime
- 2005-09-05 EP EP05019255A patent/EP1760089B1/en not_active Expired - Lifetime
- 2005-09-05 PT PT05019255T patent/PT1760089E/pt unknown
-
2006
- 2006-09-05 UA UAA200803781A patent/UA97095C2/ru unknown
- 2006-09-05 EA EA200800676A patent/EA013466B1/ru not_active IP Right Cessation
- 2006-09-05 US US12/065,725 patent/US20090274714A1/en not_active Abandoned
- 2006-09-05 DE DE602006019446T patent/DE602006019446D1/de active Active
- 2006-09-05 EP EP06777167A patent/EP1922334B1/en active Active
- 2006-09-05 ES ES06777167T patent/ES2358802T3/es active Active
- 2006-09-05 BR BRPI0615466-2A patent/BRPI0615466A2/pt not_active IP Right Cessation
- 2006-09-05 AU AU2006289289A patent/AU2006289289B2/en not_active Ceased
- 2006-09-05 UA UAA201111468A patent/UA105210C2/ru unknown
- 2006-09-05 KR KR1020087008126A patent/KR101150663B1/ko not_active Expired - Fee Related
- 2006-09-05 PL PL06777167T patent/PL1922334T3/pl unknown
- 2006-09-05 WO PCT/EP2006/008641 patent/WO2007028573A1/en not_active Ceased
- 2006-09-05 JP JP2008528437A patent/JP5132561B2/ja not_active Expired - Fee Related
- 2006-09-05 PT PT06777167T patent/PT1922334E/pt unknown
- 2006-09-05 CA CA2621414A patent/CA2621414C/en not_active Expired - Fee Related
- 2006-09-05 NZ NZ565956A patent/NZ565956A/en not_active IP Right Cessation
- 2006-09-05 SI SI200630949T patent/SI1922334T1/sl unknown
- 2006-09-05 DK DK06777167.5T patent/DK1922334T3/da active
- 2006-09-05 AT AT06777167T patent/ATE494303T1/de active
- 2006-09-05 CN CN200680038407.7A patent/CN101287755B/zh not_active Expired - Fee Related
- 2006-09-05 HR HR20110240T patent/HRP20110240T1/xx unknown
- 2006-09-05 RS RS20110146A patent/RS51893B/sr unknown
-
2008
- 2008-04-04 NO NO20081690A patent/NO20081690L/no not_active Application Discontinuation
-
2009
- 2009-10-08 CY CY20091101040T patent/CY1110536T1/el unknown
-
2011
- 2011-03-11 CY CY20111100271T patent/CY1113062T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440107T1 (de) | Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffe | |
| ATE388164T1 (de) | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden | |
| PL1642905T3 (pl) | Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1760089 Country of ref document: EP |